Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment

Neuroscience Letters

Volumn 450, Issue 3, 2009, Pages 336-339

  Nelson, Peter T ^a   Abner, Erin L ^a   Scheff, Stephen W ^a   Schmitt, Frederick A ^a   Kryscio, Richard J ^a   Jicha, Gregory A ^a   Smith, Charles D ^a   Patel, Ela ^a   Markesbery, William R ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cognition; MCI; Neuropathology; Parietal; Pathology; Posterior cingulate; Precuneus; Tissue

Indexed keywords

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID PLAQUE; ARTICLE; AUTOPSY; BRAIN REGION; CINGULATE GYRUS; COGNITIVE DEFECT; DIFFUSE AMYLOID PLAQUE; DISEASE SEVERITY; ENTORHINAL CORTEX; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PARIETAL LOBE; PATHOLOGICAL ANATOMY; PRECUNEUS; PRIORITY JOURNAL; SENILE PLAQUE; SUBICULUM; TEMPORAL CORTEX; TISSUE DISTRIBUTION;

AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; BRAIN MAPPING; COGNITION DISORDERS; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; NEOCORTEX; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; PARIETAL LOBE; SENILE PLAQUES;

EID: 58249086974     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.11.006     Document Type: Article

References (26)

1. Baron J.C., Chetelat G., Desgranges B., Perchey G., Landeau B., de la Sayette V., and Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 14 (2001) 298-309
2. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
3. Buckner R.L. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 44 (2004) 195-208
4. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., and Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25 (2005) 7709-7717
5. Caramelli P., Robitaille Y., Laroche-Cholette A., Nitrini R., Gauvreau D., Joanette Y., and Lecours A.R. Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease. Neuropsychiatry Neuropsychol. Behav. Neurol. 11 (1998) 184-190
6. Cavanna A.E., and Trimble M.R. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 129 (2006) 564-583
7. Du A.T., Schuff N., Kramer J.H., Rosen H.J., Gorno-Tempini M.L., Rankin K., Miller B.L., and Weiner M.W. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130 (2007) 1159-1166
8. Edison P., Archer H.A., Hinz R., Hammers A., Pavese N., Tai Y.F., Hotton G., Cutler D., Fox N., Kennedy A., Rossor M., and Brooks D.J. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68 (2007) 501-508
9. Frisoni G.B., Testa C., Zorzan A., Sabattoli F., Beltramello A., Soininen H., and Laakso M.P. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J. Neurol. Neurosurg. Psychiatry 73 (2002) 657-664
10. Giannakopoulos P., Duc M., Gold G., Hof P.R., Michel J.P., and Bouras C. Pathologic correlates of apraxia in Alzheimer disease. Arch. Neurol. 55 (1998) 689-695
11. Giannakopoulos P., Hof P.R., Michel J.P., Guimon J., and Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res. Brain Res. Rev. 25 (1997) 217-245
12. Herholz K., Carter S.F., and Jones M. Positron emission tomography imaging in dementia. Br. J. Radiol. 80 Spec. No. 2 (2007) S160-S167
13. Hirono N., Hashimoto M., Ishii K., Kazui H., and Mori E. One-year change in cerebral glucose metabolism in patients with Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. 16 (2004) 488-492
14. Ibanez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., and Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50 (1998) 1585-1593
15. Karas G., Scheltens P., Rombouts S., van Schijndel R., Klein M., Jones B., van der Flier W., Vrenken H., and Barkhof F. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 49 (2007) 967-976
16. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., and Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
17. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis D.G., Smith C.D., and Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 63 (2006) 38-46
18. Mintun M.A., Larossa G.N., Sheline Y.I., Dence C.S., Lee S.Y., Mach R.H., Klunk W.E., Mathis C.A., DeKosky S.T., and Morris J.C. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67 (2006) 446-452
19. Nelson P.T., Jicha G.A., Schmitt F.A., Liu H., Davis D.G., Mendiondo M.S., Abner E.L., and Markesbery W.R. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J. Neuropathol. Exp. Neurol. 66 (2007) 1136-1146
20. Nelson P.T., Kryscio R.J., Abner E.L., Schmitt F.A., Jicha G.A., Mendiondo M.S., Cooper G., Smith C.B., and Markesbery W.R. Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. J. Alzheimers Dis. (2008)
21. Petrella J.R., Wang L., Krishnan S., Slavin M.J., Prince S.E., Tran T.T., and Doraiswamy P.M. Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology 245 (2007) 224-235
22. Rowe C.C., Ng S., Ackermann U., Gong S.J., Pike K., Savage G., Cowie T.F., Dickinson K.L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochon-Danguy H., O'Keefe G., Klunk W.E., Mathis C.A., Price J.C., Masters C.L., and Villemagne V.L. Imaging beta-amyloid burden in aging and dementia. Neurology 68 (2007) 1718-1725
23. Schmitt F.A., Davis D.G., Wekstein D.R., Smith C.D., Ashford J.W., and Markesbery W.R. Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology 55 (2000) 370-376
24. Schmitt F.A., Wetherby M.M., Wekstein D.R., Dearth C.M., and Markesbery W.R. Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist 41 (2001) 716-722
25. Spreng R.N., Mar R.A., and Kim A.S. The common neural basis of autobiographical memory, prospection, navigation, theory of mind and the default mode: a quantitative meta-analysis. J. Cogn. Neurosci. (2008)
26. Vannini P., Almkvist O., Dierks T., Lehmann C., and Wahlund L.O. Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing. Psychiatry Res. 156 (2007) 43-57